ES2164103T3 - Agente hormonal para la terapia del acne y su uso. - Google Patents

Agente hormonal para la terapia del acne y su uso.

Info

Publication number
ES2164103T3
ES2164103T3 ES94916880T ES94916880T ES2164103T3 ES 2164103 T3 ES2164103 T3 ES 2164103T3 ES 94916880 T ES94916880 T ES 94916880T ES 94916880 T ES94916880 T ES 94916880T ES 2164103 T3 ES2164103 T3 ES 2164103T3
Authority
ES
Spain
Prior art keywords
hormonal
hormone
daily units
component
hormone component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916880T
Other languages
English (en)
Inventor
Marika Dr Med Ehrlich
Herbert Prof Dr Kuhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2164103(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2164103T3 publication Critical patent/ES2164103T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UN AGENTE HORMONAL PARA EL TRATAMIENTO DE ACNE CON DOS COMPONENTES HORMONALES SEPARADOS ESPACIALMENTE, AJUSTADOS DE FORMA SEPARADA EN UNA UNIDAD DE EMPAQUETADO Y DIRIGIDOS PARA ADMINISTRACION SECUENCIAL EN TIEMPO, CONSISTIENDO EN UN NUMERO DE UNIDADES DIARIAS HORMONALES DISPUESTAS DE FORMA SEPARADA ESPECIALMENTE Y EN APLICACION RETIRABLE INDIVIDUALMENTE A PARTIR DE LA UNIDAD DE EMPAQUETADO. UN PRIMER COMPONENTE HORMONAL CONTENIENDO ESENCIALMENTE COMO AGENTE ACTIVO HORMONAL SOLAMENTE UNA PREPARACION ESTROGENA ORIGINA UN INCREMENTO EN LA GLOBULINA DE ENLACE DE HORMONA DE SEXO (SHBG). EL SEGUNDO COMPONENTE HORMONAL CONTIENE UN ESTROGENO Y UNA PREPARACION ANTIANDROGENO EN COMBINACION, CARACTERIZANDOSE DE TAL MODO QUE EL NUMERO TOTAL DE UNIDADES DIARIAS ES IGUAL AL NUMERO TOTAL DE DIAS EN EL CICLO DESEADO. EL PRIMER COMPONENTE HORMONAL COMPRENDE 5 A 14 Y EL SEGUNDO COMPONENTE HORMONAL 23 A 14 UNIDADES DIARIAS, Y DE MODO QUE EL NUMERO DE UNIDADES DIARIAS DEL PRIMER COMPONENTE HORMONAL ES MENOR QUE EL DEL SEGUNDO COMPONENTE HORMONAL. LA INVENCION SE REFIERE TAMBIEN A LA UTILIZACION DE ESTE AGENTE HORMONAL.
ES94916880T 1993-07-01 1994-06-03 Agente hormonal para la terapia del acne y su uso. Expired - Lifetime ES2164103T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4321957A DE4321957C2 (de) 1993-07-01 1993-07-01 Verwendung eines hormonalen Mittels zur Therapie der Akne

Publications (1)

Publication Number Publication Date
ES2164103T3 true ES2164103T3 (es) 2002-02-16

Family

ID=6491735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94916880T Expired - Lifetime ES2164103T3 (es) 1993-07-01 1994-06-03 Agente hormonal para la terapia del acne y su uso.

Country Status (14)

Country Link
EP (1) EP0710111B1 (es)
JP (1) JPH09500112A (es)
AT (1) ATE205716T1 (es)
AU (1) AU695894B2 (es)
BR (1) BR9407340A (es)
CA (1) CA2166121A1 (es)
DE (2) DE4321957C2 (es)
DK (1) DK0710111T3 (es)
ES (1) ES2164103T3 (es)
HU (1) HUT73234A (es)
NO (1) NO308586B1 (es)
PT (1) PT710111E (es)
UA (1) UA43337C2 (es)
WO (1) WO1995001180A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534209A1 (de) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonales Mittel zur Behandlung der Haut
JP4418105B2 (ja) * 1997-12-26 2010-02-17 持田製薬株式会社 ジエノゲストを有効成分とする血管新生抑制剤
DE102004026679A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026670A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
DE102006003509A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Kontrazeptivum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU565915B2 (en) * 1982-12-31 1987-10-01 Mortimer, C.H. Pharmaceutical composition of antibiotic and anti- androgen
DE3442857A1 (de) * 1984-11-22 1986-05-22 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur behandlung von androgenisierungserscheinungen bei der frau
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4104385C1 (es) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
NO955347L (no) 1995-12-29
BR9407340A (pt) 1996-10-08
DK0710111T3 (da) 2001-12-10
PT710111E (pt) 2002-02-28
UA43337C2 (uk) 2001-12-17
HUT73234A (en) 1996-07-29
DE4321957C2 (de) 1995-09-28
EP0710111B1 (de) 2001-09-19
EP0710111A1 (de) 1996-05-08
DE4321957A1 (de) 1995-01-12
ATE205716T1 (de) 2001-10-15
HU9503770D0 (en) 1996-02-28
JPH09500112A (ja) 1997-01-07
WO1995001180A1 (de) 1995-01-12
NO955347D0 (no) 1995-12-29
AU6840894A (en) 1995-01-24
CA2166121A1 (en) 1995-01-12
DE59409869D1 (de) 2001-10-25
NO308586B1 (no) 2000-10-02
AU695894B2 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
BR9408513A (pt) Agente e método para a contracepçÃo hormonal e/ou para o tratamento de acne
ES2102921T3 (es) Utilizacion de derivados de la hormona estimuladora de los melanocitos de tipo alfa para estimular el crecimiento de los cabellos.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2191068T3 (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
ATE296612T1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
AR007582A1 (es) Composicion para el lavado de la piel, procedimiento para prepararla y el uso de la misma para la fabricacion de medicamentos dado el caso, para eltratamiento cosmetico de la piel.
AU1255002A (en) Delayed-release pharmaceutical formulations
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ITMI922331A1 (it) Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
AU695894B2 (en) Hormonal means for acne therapy and employment thereof
ATE237331T1 (de) Deuterierte wirkstoffe in transdermaler applikation
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
KR950023398A (ko) 미용죽염(美容竹鹽)
NO176003B (no) Kosmetisk preparat til hudpleie
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.
GT199400089A (es) Derivados cristalinos del acido n-acetil neuramico y proce- sos para su preparacion
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.
TH33256C3 (th) สารผสมบรรเทาผิวหนัง
UA19504A (uk) Засіб для лікуваhhя гhійhих запалеhь шкіри та підшкірhої клітковиhи
TH49366A3 (th) สารผสมบรรเทาผิวหนัง
IT1269827B (it) Bicarbonato di lidocaina, suo uso farmaceutico e composizioni che lo contengono
GR1003059B (el) Βαλσαμινοελαιολαδο προιον αναγεννησης μαλλιων

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 710111

Country of ref document: ES